Abilify and Nicoderm cq drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abilify (aripiprazole) and Nicoderm cq (nicotine). Common drug interactions include mood swings among females and emotional distress among males.

The phase IV clinical study analyzes what interactions people have when they take Abilify and Nicoderm cq. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.

What is Nicoderm cq?

Nicoderm cq has active ingredients of nicotine. It is often used in quit smoking. eHealthMe is studying from 18,564 Nicoderm cq users. Check the latest studies of Nicoderm cq.



On Jul, 16, 2026

31 people who take Abilify and Nicoderm cq together, and have interactions are studied.

Abilify and Nicoderm cq drug interactions.

What are the common drug interactions of Abilify and Nicoderm Cq, by gender? *:

female:

  1. Mood swings (an extreme or rapid change in mood)
  2. Oedema (fluid collection in tissue)
  3. Schizophrenia (a mental disorder characterized by a breakdown of thought processes)
  4. Abdominal pain upper
  5. Abnormal behaviour
  6. Acne (skin problems that cause pimples)
  7. Activities of daily living impaired
  8. Akathisia (a movement disorder characterized by a feeling of inner restlessness)
  9. Angiotensin converting enzyme decreased
  10. Arthralgia (joint pain)

male:

  1. Emotional distress
  2. Pain
  3. Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;)
  4. Aggression
  5. Fall
  6. Femoral neck fracture (neck of femur bone fracture)
  7. Gait disturbance
  8. Head injury
  9. Osteopenia (a condition where bone mineral density is lower than normal)
  10. Osteoporosis (bones weak and more likely to break)

What are the common drug interactions of Abilify and Nicoderm Cq, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Pain
  2. Pelvic inflammatory disease
  3. Periorbital oedema (swelling around the eyes)
  4. Personality change
  5. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  6. Somnolence (a state of near-sleep, a strong desire for sleep)
  7. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  8. Tremor (trembling or shaking movements in one or more parts of your body)
  9. Underweight
  10. Vaginal haemorrhage (vaginal bleeding)

30-39:

  1. Headache (pain in head)
  2. Myocarditis (inflammation of heart muscle myocardium)
  3. Ventricular hypokinesia (muscle of one's heart does not contract as much as most peoples' hearts do)
  4. Detoxification
  5. Hospitalisation
  6. Seizure (abnormal excessive or synchronous neuronal activity in the brain)

40-49:

  1. Pain
  2. Abnormal dreams
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anxiety
  5. Bone density decreased
  6. Chondropathy (disease of the cartilage)
  7. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  8. Dizziness
  9. Emotional distress
  10. Fatigue (feeling of tiredness)

50-59:

  1. Bone density decreased
  2. Emotional distress
  3. Fall
  4. Femoral neck fracture (neck of femur bone fracture)
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Osteomalacia (softening of the bones due to a lack of vitamin d)
  7. Osteopenia (a condition where bone mineral density is lower than normal)
  8. Osteoporosis (bones weak and more likely to break)
  9. Osteoporotic fracture (fracture due to weak bone)
  10. Pain

60+:

  1. Lower limb fracture
  2. Disability
  3. Fall
  4. Spinal cord compression
  5. Dislocation of vertebra

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 25.81%
  2. Hiv Infection: 5 people, 16.13%
  3. Pain: 4 people, 12.90%
  4. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 3 people, 9.68%
  5. Neuralgia (pain in one or more nerves): 2 people, 6.45%
  6. Nausea (feeling of having an urge to vomit): 2 people, 6.45%
  7. Insomnia (sleeplessness): 2 people, 6.45%
  8. Headache (pain in head): 2 people, 6.45%
  9. Bipolar Disorder (mood disorder): 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and Nicoderm cq?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Abilify and Nicoderm cq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nicoderm cq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abilify and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nicoderm cq and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole and nicotine (the active ingredients of Abilify and Nicoderm cq, respectively), and Abilify and Nicoderm cq (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: